Hi there Leverage.
I'm reading behind the lines of the announcement and it's all good. If the market was to take notice of anything it may be the following:
" Two of Cellmid’s MK antibodies have shown tumour supressing ability in glioblastoma cell lines resistant to cannabinoid treatment in studies conducted at the labs of Professor Guillermo Velasco of Computense University in Madrid. "
The rest is all very relevant and points clearly to key partnerships however it is the Computense study that is nearing Stage 1...... and which would align very closely with ongoing clinical work by GW Pharma.
cheers
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.474M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1280000 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 332362 | 2 |
View Market Depth
| Last trade - 16.30pm 17/07/2025 (20 minute delay) ? |
| AN1 (ASX) Chart |
Day chart unavailable